Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
NYSE:EBS
Emergent Biosolutions (EBS) Ownership Overview
3.68% Insiders
11.17% Mutual Funds
11.15% Other Institutional Investors
19.21% ETFs
54.79% Public Companies and
Individual Investors
The ownership structure of Emergent Biosolutions (EBS) stock is a mix of institutional, retail, and individual investors. Approximately 41.53% of the company’s stock is owned by Institutional Investors, 3.68% is owned by Insiders, and 54.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 12, 2025 | Kathryn C Zoon Director | xxxxxxxxxxxxx | $57300 |
| Mar 12, 2025 | Neal Franklin Fowler Director | xxxxxxxxxxxxx | $204050 |
| Nov 14, 2024 | Donald W Degolyer Director | xxxxxxxxxxxxx | $272750 |
| Nov 13, 2024 | Marvin White Director | xxxxxxxxxxxxx | $171015 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $134394 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $199880 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $200760 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $384034 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,571,495 | Institution | 4.73% | 14,683,236 | |
| 2,361,790 | Institution | 4.35% | 13,485,821 | |
| 2,064,783 | Institution | 3.80% | 11,789,911 | |
| 1,511,803 | Institution | 2.78% | 8,632,395 | |
| 1,416,787 | Institution | 2.61% | 8,089,854 | |
| 1,113,338 | Institution | 2.05% | 6,357,160 | |
| 1,105,807 | Institution | 2.04% | 6,314,158 | |
| 826,703 | Institution | 1.52% | 4,720,474 | |
| 582,973 | Institution | 1.07% | 3,328,776 | |
| 543,074 | Institution | 1.00% | 3,100,953 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,361,790 | Institution | 4.35% | 13,485,821 | |
| 826,703 | Institution | 1.52% | 4,720,474 | |
| 543,074 | Institution | 1.00% | 3,100,953 | |
| 496,915 | Institution | 0.91% | 2,837,385 | |
| 330,286 | Institution | 0.61% | 1,885,933 | |
| 244,455 | Institution | 0.45% | 1,395,838 | |
| 178,500 | Institution | 0.33% | 1,019,235 | |
| 178,244 | Institution | 0.33% | 1,017,773 | |
| 158,614 | Institution | 0.29% | 905,686 | |
| 134,818 | Institution | 0.25% | 769,811 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,928,303 | Institution | 3.55% | 11,010,610 | |
| 1,572,846 | Institution | 2.89% | 11,764,888 | |
| 1,511,803 | Institution | 2.78% | 8,330,035 | |
| 925,415 | Institution | 1.70% | 5,284,120 | |
| 827,407 | Institution | 1.52% | 6,189,004 | |
| 814,931 | Institution | 1.50% | 4,490,270 | |
| 491,372 | Institution | 0.90% | 2,805,734 | |
| 316,036 | Institution | 0.58% | 1,804,566 | |
| 256,581 | Institution | 0.47% | 1,413,761 | |
| 255,952 | Institution | 0.47% | 1,410,296 |
FAQ
Who Owns Emergent Biosolutions (EBS)?
According to the latest TipRanks data, approximately 11.15% of the company's stock is held by institutional investors, 3.68% is held by insiders, and 54.79% is held by retail investors.
What percentage of Emergent Biosolutions (EBS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.15% of Emergent Biosolutions (EBS) stock is held by institutional investors.
What percentage of Emergent Biosolutions (EBS) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.79% of Emergent Biosolutions (EBS) stock is held by retail investors.
Who owns the most shares of Emergent Biosolutions (EBS)?
Vanguard owns the most shares of Emergent Biosolutions (EBS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.